Epana Bio
Reset immunity. Restore health.
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- epana.bio
About
Epana Bio develops precision therapies that treat autoimmune disease by targeting its cellular origin. The company uses genomics and AI to accelerate the design of medicines tailored specifically to patients, aiming to reset immunity and restore health. It believes patients with autoimmune disease deserve therapies designed for them, and that small, focused teams can transform how those patients are cared for.
Summary
Epana Bio is an Artificial Intelligence company, founded in 2024.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epana-bio"><img src="https://indexed.vc/api/badge/company/epana-bio" alt="Epana Bio on Indexed.vc" width="260" height="76" /></a>